FDA Orders UCLA Researchers To End Promotional Claims About Brain Scan Using Unapproved Drug
FDA has ordered two UCLA researchers to cease making promotional claims about an experimental brain scan. The researchers claimed that injecting patients with the radioactive compound FDDNP before a brain scan could help identify concussions and forms of dementia, but FDA found the claims violated federal law against promoting unapproved drugs.
- "FDA Forces UCLA Researchers To Stop Touting Experimental Dementia Scan" (Zarembo, "Science Now," Los Angeles Times, 4/10).